SA Pharmaceutical Journal - Volume 82, Issue 2, 2015
Volume 82, Issue 2, 2015
Author Lorraine OsmanSource: SA Pharmaceutical Journal 82 (2015)More Less
This month, I'm battling to get my mind, what's left of it, around Pharmacy Week. Yes, I do know that Pharmacy Week was in September. That hasn't changed. Yet. If you go to the PSSA Perspectives page, you'll see why I'm living in the past, while at the same time grappling with the present, and trying to fast forward to the future.
Author Johann KrugerSource: SA Pharmaceutical Journal 82 (2015)More Less
As pharmacists, we have been trained on drugs; on their pharmacodynamic and pharmacokinetic effects, side-effects, chemical composition and how to look for drug-drug, drug-food and drug-genetic interactions. When we have consulted with the patient and determined the best possible treatment, he or she walks out of the door of the pharmacy, and we feel satisfied that we have achieved the best that is possible in the patient's interests, and consider it a job well done. But is it? Does our professional responsibility stop when that patient leaves the door? It does not seem to be the case at all.
Author Stephani SchmidtSource: SA Pharmaceutical Journal 82, pp 12 –16 (2015)More Less
Influenza, commonly known as "flu", is a contagious respiratory illness caused by influenza viruses that infect the nose, throat and lungs. Outbreaks usually occur during the winter months in the Northern and Southern Hemispheres. However, they may occur throughout the year in the tropics. The epidemiological pattern reflects the changing nature of the antigenic properties of the influenza viruses. Their subsequent spread depends upon several factors, including transmissibility of the virus and the vulnerability of the population. They can cause mild to severe illness, and at times can lead to death. Annual epidemics are estimated to result in approximately 3-5 million cases of severe illness, and approximately 250 000-500 000 deaths worldwide. Increased rates of morbidity and mortality occur at the extremes of age and in individuals with underlying co-morbidities. However, higher rates of mortality also occur in young adults during pandemics.
Source: SA Pharmaceutical Journal 82, pp 17 –25 (2015)More Less
This article provides an overview of the changes that have taken place in the diagnosis and management of hypertension over the past decade. Hypertension remains a very common condition seen in South Africa. The approach to the management of hypertension includes necessary lifestyle modifications and a decisive, stepwise escalation process in the pharmacotherapeutic management thereof. Thiazide diuretics are still being promoted by most guidelines to be the initial (first-line) drug of choice, with the addition of other suitable antihypertensive agents, if necessary, and according to any relevant co-morbid conditions.
Author Lynn LambertSource: SA Pharmaceutical Journal 82, pp 26 –29 (2015)More Less
The experience of pain is a complex, multifaceted unpleasant sensory and emotional experience. Pain has been recognised as a global burden, and postoperative pain is one of the most common types. Postoperative pain is a complication of surgery, which, in turn, complicates recovery. Lack of appropriate postoperative analgesic management has a significant impact on clinical and economic outcomes. A multimodal approach, that incorporates different drugs and techniques, has been demonstrated as being the most effective way of reducing postoperative pain.
Source: SA Pharmaceutical Journal 82, pp 32 –34 (2015)More Less
The abnormal death of neurons in the central nervous system of individuals suffering from neurodegenerative diseases, which include Parkinson's disease, Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis, takes place by an intrinsic cell suicide programme, known as apoptosis. This process is triggered by several stimuli, and consists of numerous pathways and cascades which lead to apoptosis.
Author Stephan MollerSource: SA Pharmaceutical Journal 82, pp 35 –37 (2015)More Less
Two years ago, when I set sails as SAAHIP President, the task at hand seemed overwhelming and without end. Yet, as I write this report, time has been too short. Be that as it may, sometimes we make the process more complicated than we need to. The national executive committee (NEC) with whom I was blessed to work has held me firm and high, and I am certain that my successor will be supported in equal measure. I say this to the president elect: We will never make a journey of a thousand miles by fretting about how long it will take, or how hard it will be. We make the journey by taking each day step by step, and then repeating it again and again, until we reach our destination.
Her Royal Highness, the Crown Princess Mary of Denmark, visited the Gender Based Violence Command Centre : newsSource: SA Pharmaceutical Journal 82 (2015)More Less
Her Royal Highness (HRH), the Crown Princess Mary of Denmark, the Danish delegation and the United Nations Population Fund visited the Gender Based Violence (GBV) Command Centre on 5 November 2014. Past PSSA President, Dr Sybil Seoka, was there to welcome her and to open the meeting.